EMEA (Europe, Middle East and Africa) Human Vaccines Market Report 2017

December 2017 | 115 pages | ID: E92014010F2EN
QYResearch

Abstracts

In this report, the EMEA Human Vaccines market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (), revenue (Million USD), market share and growth rate of Human Vaccines for these regions, from 2012 to 2022 (forecast)

• Europe: Germany, France, UK, Russia, Italy and Benelux;
• Middle East: Saudi Arabia, Israel, UAE and Iran;
• Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Human Vaccines market competition by top manufacturers/players, with Human Vaccines sales volume (), price (), revenue (Million USD) and market share for each manufacturer/player; the top players including

• AstraZeneca
• Bavarian Nordic
• Bharat Biotech
• CSL Limited
• Emergent BioSolutions, Inc.
• GlaxoSmithKline plc
• Johnson & Johnson
• Merck & Co., Inc.
• Mymetics
• Novartis AG
• Pfizer, Inc.
• Sanofi
• Shenzhen Kangtai Biological Products Co., Ltd.
• Takeda Pharmaceutical Company Limited.

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into

• Pneumococcal
• Influenza
• Hepatitis
• HPV
• Meningococcal
• Rotavirus
• Measles
• Typhoid
• Combination

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

• Pediatrics
• Adolescents
• Adults
• Geriatrics

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

EMEA (Europe, Middle East and Africa) Human Vaccines Market Report 2017

1 HUMAN VACCINES OVERVIEW

1.1 Product Overview and Scope of Human Vaccines
1.2 Classification of Human Vaccines
  1.2.1 EMEA Human Vaccines Market Size (Sales) Comparison by Type (2012-2022)
  1.2.2 EMEA Human Vaccines Market Size (Sales) Market Share by Type (Product Category) in 2016
  1.2.3 Pneumococcal
  1.2.4 Influenza
  1.2.5 Hepatitis
  1.2.6 HPV
  1.2.7 Meningococcal
  1.2.8 Rotavirus
  1.2.9 Measles
  1.2.10 Typhoid
  1.2.11 Combination
1.3 EMEA Human Vaccines Market by Application/End Users
  1.3.1 EMEA Human Vaccines Sales (Volume) and Market Share Comparison by Application (2012-2022
  1.3.2 Pediatrics
  1.3.3 Adolescents
  1.3.4 Adults
  1.3.5 Geriatrics
1.4 EMEA Human Vaccines Market by Region
  1.4.1 EMEA Human Vaccines Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 Europe Status and Prospect (2012-2022)
  1.4.3 Middle East Status and Prospect (2012-2022)
  1.4.4 Africa Status and Prospect (2012-2022)
1.5 EMEA Market Size (Value and Volume) of Human Vaccines (2012-2022)
  1.5.1 EMEA Human Vaccines Sales and Growth Rate (2012-2022)
  1.5.2 EMEA Human Vaccines Revenue and Growth Rate (2012-2022)

2 EMEA HUMAN VACCINES COMPETITION BY MANUFACTURERS/PLAYERS/SUPPLIERS, REGION, TYPE AND APPLICATION

2.1 EMEA Human Vaccines Market Competition by Players/Manufacturers
  2.1.1 EMEA Human Vaccines Sales Volume and Market Share of Major Players (2012-2017)
  2.1.2 EMEA Human Vaccines Revenue and Share by Players (2012-2017)
  2.1.3 EMEA Human Vaccines Sale Price by Players (2012-2017)
2.2 EMEA Human Vaccines (Volume and Value) by Type/Product Category
  2.2.1 EMEA Human Vaccines Sales and Market Share by Type (2012-2017)
  2.2.2 EMEA Human Vaccines Revenue and Market Share by Type (2012-2017)
  2.2.3 EMEA Human Vaccines Sale Price by Type (2012-2017)
2.3 EMEA Human Vaccines (Volume) by Application
2.4 EMEA Human Vaccines (Volume and Value) by Region
  2.4.1 EMEA Human Vaccines Sales and Market Share by Region (2012-2017)
  2.4.2 EMEA Human Vaccines Revenue and Market Share by Region (2012-2017)
  2.4.3 EMEA Human Vaccines Sales Price by Region (2012-2017)

3 EUROPE HUMAN VACCINES (VOLUME, VALUE AND SALES PRICE), BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

3.1 Europe Human Vaccines Sales and Value (2012-2017)
  3.1.1 Europe Human Vaccines Sales Volume and Growth Rate (2012-2017)
  3.1.2 Europe Human Vaccines Revenue and Growth Rate (2012-2017)
3.2 Europe Human Vaccines Sales and Market Share by Type
3.3 Europe Human Vaccines Sales and Market Share by Application
3.4 Europe Human Vaccines Sales Volume and Value (Revenue) by Countries
  3.4.1 Europe Human Vaccines Sales Volume by Countries (2012-2017)
  3.4.2 Europe Human Vaccines Revenue by Countries (2012-2017)
  3.4.3 Germany Human Vaccines Sales and Growth Rate (2012-2017)
  3.4.4 France Human Vaccines Sales and Growth Rate (2012-2017)
  3.4.5 UK Human Vaccines Sales and Growth Rate (2012-2017)
  3.4.6 Russia Human Vaccines Sales and Growth Rate (2012-2017)
  3.4.7 Italy Human Vaccines Sales and Growth Rate (2012-2017)
  3.4.8 Benelux Human Vaccines Sales and Growth Rate (2012-2017)

4 MIDDLE EAST HUMAN VACCINES (VOLUME, VALUE AND SALES PRICE), BY REGION, TYPE AND APPLICATION

4.1 Middle East Human Vaccines Sales and Value (2012-2017)
  4.1.1 Middle East Human Vaccines Sales Volume and Growth Rate (2012-2017)
  4.1.2 Middle East Human Vaccines Revenue and Growth Rate (2012-2017)
4.2 Middle East Human Vaccines Sales and Market Share by Type
4.3 Middle East Human Vaccines Sales and Market Share by Application
4.4 Middle East Human Vaccines Sales Volume and Value (Revenue) by Countries
  4.4.1 Middle East Human Vaccines Sales Volume by Countries (2012-2017)
  4.4.2 Middle East Human Vaccines Revenue by Countries (2012-2017)
  4.4.3 Saudi Arabia Human Vaccines Sales and Growth Rate (2012-2017)
  4.4.4 Israel Human Vaccines Sales and Growth Rate (2012-2017)
  4.4.5 UAE Human Vaccines Sales and Growth Rate (2012-2017)
  4.4.6 Iran Human Vaccines Sales and Growth Rate (2012-2017)

5 AFRICA HUMAN VACCINES (VOLUME, VALUE AND SALES PRICE) BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

5.1 Africa Human Vaccines Sales and Value (2012-2017)
  5.1.1 Africa Human Vaccines Sales Volume and Growth Rate (2012-2017)
  5.1.2 Africa Human Vaccines Revenue and Growth Rate (2012-2017)
5.2 Africa Human Vaccines Sales and Market Share by Type
5.3 Africa Human Vaccines Sales and Market Share by Application
5.4 Africa Human Vaccines Sales Volume and Value (Revenue) by Countries
  5.4.1 Africa Human Vaccines Sales Volume by Countries (2012-2017)
  5.4.2 Africa Human Vaccines Revenue by Countries (2012-2017)
  5.4.3 South Africa Human Vaccines Sales and Growth Rate (2012-2017)
  5.4.4 Nigeria Human Vaccines Sales and Growth Rate (2012-2017)
  5.4.5 Egypt Human Vaccines Sales and Growth Rate (2012-2017)
  5.4.6 Algeria Human Vaccines Sales and Growth Rate (2012-2017)

6 EMEA HUMAN VACCINES MANUFACTURERS/PLAYERS PROFILES AND SALES DATA

6.1 AstraZeneca
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Human Vaccines Product Type, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 AstraZeneca Human Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Bavarian Nordic
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 Human Vaccines Product Type, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Bavarian Nordic Human Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Bharat Biotech
  6.3.1 Company Basic Information, Manufacturing Base and Competitors
  6.3.2 Human Vaccines Product Type, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Bharat Biotech Human Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 CSL Limited
  6.4.1 Company Basic Information, Manufacturing Base and Competitors
  6.4.2 Human Vaccines Product Type, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 CSL Limited Human Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Emergent BioSolutions, Inc.
  6.5.1 Company Basic Information, Manufacturing Base and Competitors
  6.5.2 Human Vaccines Product Type, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Emergent BioSolutions, Inc. Human Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 GlaxoSmithKline plc
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 Human Vaccines Product Type, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 GlaxoSmithKline plc Human Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Johnson & Johnson
  6.7.1 Company Basic Information, Manufacturing Base and Competitors
  6.7.2 Human Vaccines Product Type, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Johnson & Johnson Human Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 Merck & Co., Inc.
  6.8.1 Company Basic Information, Manufacturing Base and Competitors
  6.8.2 Human Vaccines Product Type, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Merck & Co., Inc. Human Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 Mymetics
  6.9.1 Company Basic Information, Manufacturing Base and Competitors
  6.9.2 Human Vaccines Product Type, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Mymetics Human Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview
6.10 Novartis AG
  6.10.1 Company Basic Information, Manufacturing Base and Competitors
  6.10.2 Human Vaccines Product Type, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 Novartis AG Human Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
  6.10.4 Main Business/Business Overview
6.11 Pfizer, Inc.
6.12 Sanofi
6.13 Shenzhen Kangtai Biological Products Co., Ltd.
6.14 Takeda Pharmaceutical Company Limited.

7 HUMAN VACCINES MANUFACTURING COST ANALYSIS

7.1 Human Vaccines Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Human Vaccines

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Human Vaccines Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Human Vaccines Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 EMEA HUMAN VACCINES MARKET FORECAST (2017-2022)

11.1 EMEA Human Vaccines Sales, Revenue and Price Forecast (2017-2022)
  11.1.1 EMEA Human Vaccines Sales and Growth Rate Forecast (2017-2022)
  11.1.2 EMEA Human Vaccines Revenue and Growth Rate Forecast (2017-2022)
  11.1.3 EMEA Human Vaccines Price and Trend Forecast (2017-2022)
11.2 EMEA Human Vaccines Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.3 Europe Human Vaccines Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.4 Middle Eastt Human Vaccines Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.5 Africa Human Vaccines Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.6 EMEA Human Vaccines Sales Forecast by Type (2017-2022)
11.7 EMEA Human Vaccines Sales Forecast by Application (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Human Vaccines
Figure EMEA Human Vaccines Sales Volume () by Type (2012-2022)
Figure EMEA Human Vaccines Sales Volume Market Share by Type (Product Category) in 2016
Figure Pneumococcal Product Picture
Figure Influenza Product Picture
Figure Hepatitis Product Picture
Figure HPV Product Picture
Figure Meningococcal Product Picture
Figure Rotavirus Product Picture
Figure Measles Product Picture
Figure Typhoid Product Picture
Figure Combination Product Picture
Figure EMEA Human Vaccines Sales Volume () by Application (2012-2022)
Figure EMEA Sales Market Share of Human Vaccines by Application in 2016
Figure Pediatrics Examples
Table Key Downstream Customer in Pediatrics
Figure Adolescents Examples
Table Key Downstream Customer in Adolescents
Figure Adults Examples
Table Key Downstream Customer in Adults
Figure Geriatrics Examples
Table Key Downstream Customer in Geriatrics
Figure EMEA Human Vaccines Market Size (Million USD) by Region (2012-2022)
Figure Europe Human Vaccines Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Human Vaccines Revenue (Million USD) Status and Forecast by Countries
Figure Middle East Human Vaccines Revenue (Million USD) and Growth Rate (2012-2022)
Figure Middle East Human Vaccines Revenue (Million USD) Status and Forecast by Countries
Figure Africa Human Vaccines Revenue (Million USD) and Growth Rate (2012-2022)
Figure Africa Human Vaccines Revenue (Million USD) Status and Forecast by Countries
Figure EMEA Human Vaccines Sales Volume and Growth Rate (2012-2022)
Figure EMEA Human Vaccines Revenue (Million USD) and Growth Rate (2012-2022)
Figure EMEA Human Vaccines Market Major Players Product Sales Volume () (2012-2017)
Table EMEA Human Vaccines Sales Volume () of Major Players (2012-2017)
Table EMEA Human Vaccines Sales Share by Players (2012-2017)
Figure 2016 Human Vaccines Sales Share by Players
Figure 2017 Human Vaccines Sales Share by Players
Figure EMEA Human Vaccines Market Major Players Product Revenue (Million USD) (2012-2017)
Table EMEA Human Vaccines Revenue (Million USD) by Players (2012-2017)
Table EMEA Human Vaccines Revenue Share by Players (2012-2017)
Table 2016 EMEA Human Vaccines Revenue Share by Players
Table 2017 EMEA Human Vaccines Revenue Share by Players
Table EMEA Human Vaccines Sale Price () by Players (2012-2017)
Table EMEA Human Vaccines Sales () and Market Share by Type (2012-2017)
Table EMEA Human Vaccines Sales Share by Type (2012-2017)
Figure Sales Market Share of Human Vaccines by Type (2012-2017)
Figure EMEA Human Vaccines Sales Market Share by Type (2012-2017)
Table EMEA Human Vaccines Revenue (Million USD) and Market Share by Type (2012-2017)
Table EMEA Human Vaccines Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Human Vaccines by Type in 2016
Table EMEA Human Vaccines Sale Price () by Type (2012-2017)
Table EMEA Human Vaccines Sales () and Market Share by Application (2012-2017)
Table EMEA Human Vaccines Sales Share by Application (2012-2017)
Figure Sales Market Share of Human Vaccines by Application (2012-2017)
Figure EMEA Human Vaccines Sales Market Share by Application in 2016
Table EMEA Human Vaccines Sales () and Market Share by Region (2012-2017)
Table EMEA Human Vaccines Sales Share by Region (2012-2017)
Figure Sales Market Share of Human Vaccines by Region (2012-2017)
Figure EMEA Human Vaccines Sales Market Share in 2016
Table EMEA Human Vaccines Revenue (Million USD) and Market Share by Region (2012-2017)
Table EMEA Human Vaccines Revenue Share by Region (2012-2017)
Figure Revenue Market Share of Human Vaccines by Region (2012-2017)
Figure EMEA Human Vaccines Revenue Market Share Regions in 2016
Table EMEA Human Vaccines Sales Price () by Region (2012-2017)
Figure Europe Human Vaccines Sales () and Growth Rate (2012-2017)
Figure Europe Human Vaccines Revenue and Growth Rate (2012-2017)
Table Europe Human Vaccines Sales () by Type (2012-2017)
Table Europe Human Vaccines Market Share by Type (2012-2017)
Figure Europe Human Vaccines Market Share by Type in 2016
Table Europe Human Vaccines Sales () by Application (2012-2017)
Table Europe Human Vaccines Market Share by Application (2012-2017)
Figure Europe Human Vaccines Market Share by Application in 2016
Table Europe Human Vaccines Sales () by Countries (2012-2017)
Table Europe Human Vaccines Sales Market Share by Countries (2012-2017)
Figure Europe Human Vaccines Sales Market Share by Countries (2012-2017)
Figure Europe Human Vaccines Sales Market Share by Countries in 2016
Table Europe Human Vaccines Revenue (Million USD) by Countries (2012-2017)
Table Europe Human Vaccines Revenue Market Share by Countries (2012-2017)
Figure Europe Human Vaccines Revenue Market Share by Countries (2012-2017)
Figure Europe Human Vaccines Revenue Market Share by Countries in 2016
Figure Germany Human Vaccines Sales () and Growth Rate (2012-2017)
Figure France Human Vaccines Sales () and Growth Rate (2012-2017)
Figure UK Human Vaccines Sales () and Growth Rate (2012-2017)
Figure Russia Human Vaccines Sales () and Growth Rate (2012-2017)
Figure Italy Human Vaccines Sales () and Growth Rate (2012-2017)
Figure Benelux Human Vaccines Sales () and Growth Rate (2012-2017)
Figure Middle East Human Vaccines Sales () and Growth Rate (2012-2017)
Figure Middle East Human Vaccines Revenue (Million USD) and Growth Rate (2012-2017)
Table Middle East Human Vaccines Sales () by Type (2012-2017)
Table Middle East Human Vaccines Market Share by Type (2012-2017)
Figure Middle East Human Vaccines Market Share by Type (2012-2017)
Table Middle East Human Vaccines Sales () by Applications (2012-2017)
Table Middle East Human Vaccines Market Share by Applications (2012-2017)
Figure Middle East Human Vaccines Sales Market Share by Application in 2016
Table Middle East Human Vaccines Sales Volume () by Countries (2012-2017)
Table Middle East Human Vaccines Sales Volume Market Share by Countries (2012-2017)
Figure Middle East Human Vaccines Sales Volume Market Share by Countries in 2016
Table Middle East Human Vaccines Revenue (Million USD) by Countries (2012-2017)
Table Middle East Human Vaccines Revenue Market Share by Countries (2012-2017)
Figure Middle East Human Vaccines Revenue Market Share by Countries (2012-2017)
Figure Middle East Human Vaccines Revenue Market Share by Countries in 2016
Figure Saudi Arabia Human Vaccines Sales () and Growth Rate (2012-2017)
Figure Israel Human Vaccines Sales () and Growth Rate (2012-2017)
Figure UAE Human Vaccines Sales () and Growth Rate (2012-2017)
Figure Iran Human Vaccines Sales () and Growth Rate (2012-2017)
Figure Africa Human Vaccines Sales () and Growth Rate (2012-2017)
Figure Africa Human Vaccines Revenue (Million USD) and Growth Rate (2012-2017)
Table Africa Human Vaccines Sales () by Type (2012-2017)
Table Africa Human Vaccines Sales Market Share by Type (2012-2017)
Figure Africa Human Vaccines Sales Market Share by Type (2012-2017)
Figure Africa Human Vaccines Sales Market Share by Type in 2016
Table Africa Human Vaccines Sales () by Application (2012-2017)
Table Africa Human Vaccines Sales Market Share by Application (2012-2017)
Figure Africa Human Vaccines Sales Market Share by Application (2012-2017)
Table Africa Human Vaccines Sales Volume () by Countries (2012-2017)
Table Africa Human Vaccines Sales Market Share by Countries (2012-2017)
Figure Africa Human Vaccines Sales Market Share by Countries (2012-2017)
Figure Africa Human Vaccines Sales Market Share by Countries in 2016
Table Africa Human Vaccines Revenue (Million USD) by Countries (2012-2017)
Table Africa Human Vaccines Revenue Market Share by Countries (2012-2017)
Figure Africa Human Vaccines Revenue Market Share by Countries (2012-2017)
Figure Africa Human Vaccines Revenue Market Share by Countries in 2016
Figure South Africa Human Vaccines Sales () and Growth Rate (2012-2017)
Figure Nigeria Human Vaccines Sales () and Growth Rate (2012-2017)
Figure Egypt Human Vaccines Sales () and Growth Rate (2012-2017)
Figure Algeria Human Vaccines Sales () and Growth Rate (2012-2017)
Table AstraZeneca Human Vaccines Basic Information List
Table AstraZeneca Human Vaccines Sales (), Revenue (Million USD), Price () and Gross Margin (2012-2017)
Figure AstraZeneca Human Vaccines Sales () and Growth Rate (2012-2017)
Figure AstraZeneca Human Vaccines Sales Market Share in EMEA (2012-2017)
Figure AstraZeneca Human Vaccines Revenue Market Share in EMEA (2012-2017)
Table Bavarian Nordic Human Vaccines Basic Information List
Table Bavarian Nordic Human Vaccines Sales (), Revenue (Million USD), Price () and Gross Margin (2012-2017)
Figure Bavarian Nordic Human Vaccines Sales () and Growth Rate (2012-2017)
Figure Bavarian Nordic Human Vaccines Sales Market Share in EMEA (2012-2017)
Figure Bavarian Nordic Human Vaccines Revenue Market Share in EMEA (2012-2017)
Table Bharat Biotech Human Vaccines Basic Information List
Table Bharat Biotech Human Vaccines Sales (), Revenue (Million USD), Price () and Gross Margin (2012-2017)
Figure Bharat Biotech Human Vaccines Sales () and Growth Rate (2012-2017)
Figure Bharat Biotech Human Vaccines Sales Market Share in EMEA (2012-2017)
Figure Bharat Biotech Human Vaccines Revenue Market Share in EMEA (2012-2017)
Table CSL Limited Human Vaccines Basic Information List
Table CSL Limited Human Vaccines Sales (), Revenue (Million USD), Price () and Gross Margin (2012-2017)
Figure CSL Limited Human Vaccines Sales () and Growth Rate (2012-2017)
Figure CSL Limited Human Vaccines Sales Market Share in EMEA (2012-2017)
Figure CSL Limited Human Vaccines Revenue Market Share in EMEA (2012-2017)
Table Emergent BioSolutions, Inc. Human Vaccines Basic Information List
Table Emergent BioSolutions, Inc. Human Vaccines Sales (), Revenue (Million USD), Price () and Gross Margin (2012-2017)
Figure Emergent BioSolutions, Inc. Human Vaccines Sales () and Growth Rate (2012-2017)
Figure Emergent BioSolutions, Inc. Human Vaccines Sales Market Share in EMEA (2012-2017)
Figure Emergent BioSolutions, Inc. Human Vaccines Revenue Market Share in EMEA (2012-2017)
Table GlaxoSmithKline plc Human Vaccines Basic Information List
Table GlaxoSmithKline plc Human Vaccines Sales (), Revenue (Million USD), Price () and Gross Margin (2012-2017)
Figure GlaxoSmithKline plc Human Vaccines Sales () and Growth Rate (2012-2017)
Figure GlaxoSmithKline plc Human Vaccines Sales Market Share in EMEA (2012-2017)
Figure GlaxoSmithKline plc Human Vaccines Revenue Market Share in EMEA (2012-2017)
Table Johnson & Johnson Human Vaccines Basic Information List
Table Johnson & Johnson Human Vaccines Sales (), Revenue (Million USD), Price () and Gross Margin (2012-2017)
Figure Johnson & Johnson Human Vaccines Sales () and Growth Rate (2012-2017)
Figure Johnson & Johnson Human Vaccines Sales Market Share in EMEA (2012-2017)
Figure Johnson & Johnson Human Vaccines Revenue Market Share in EMEA (2012-2017)
Table Merck & Co., Inc. Human Vaccines Basic Information List
Table Merck & Co., Inc. Human Vaccines Sales (), Revenue (Million USD), Price () and Gross Margin (2012-2017)
Figure Merck & Co., Inc. Human Vaccines Sales () and Growth Rate (2012-2017)
Figure Merck & Co., Inc. Human Vaccines Sales Market Share in EMEA (2012-2017)
Figure Merck & Co., Inc. Human Vaccines Revenue Market Share in EMEA (2012-2017)
Table Mymetics Human Vaccines Basic Information List
Table Mymetics Human Vaccines Sales (), Revenue (Million USD), Price () and Gross Margin (2012-2017)
Figure Mymetics Human Vaccines Sales () and Growth Rate (2012-2017)
Figure Mymetics Human Vaccines Sales Market Share in EMEA (2012-2017)
Figure Mymetics Human Vaccines Revenue Market Share in EMEA (2012-2017)
Table Novartis AG Human Vaccines Basic Information List
Table Novartis AG Human Vaccines Sales (), Revenue (Million USD), Price () and Gross Margin (2012-2017)
Figure Novartis AG Human Vaccines Sales () and Growth Rate (2012-2017)
Figure Novartis AG Human Vaccines Sales Market Share in EMEA (2012-2017)
Figure Novartis AG Human Vaccines Revenue Market Share in EMEA (2012-2017)
Table Pfizer, Inc. Human Vaccines Basic Information List
Table Sanofi Human Vaccines Basic Information List
Table Shenzhen Kangtai Biological Products Co., Ltd. Human Vaccines Basic Information List
Table Takeda Pharmaceutical Company Limited. Human Vaccines Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Human Vaccines
Figure Manufacturing Process Analysis of Human Vaccines
Figure Human Vaccines Industrial Chain Analysis
Table Raw Materials Sources of Human Vaccines Major Manufacturers in 2016
Table Major Buyers of Human Vaccines
Table Distributors/Traders List
Figure EMEA Human Vaccines Sales () and Growth Rate Forecast (2017-2022)
Figure EMEA Human Vaccines Revenue and Growth Rate Forecast (2017-2022)
Figure EMEA Human Vaccines Price () and Trend Forecast (2017-2022)
Table EMEA Human Vaccines Sales () Forecast by Region (2017-2022)
Figure EMEA Human Vaccines Sales Market Share Forecast by Region (2017-2022)
Table EMEA Human Vaccines Revenue (Million USD) Forecast by Region (2017-2022)
Figure EMEA Human Vaccines Revenue Market Share Forecast by Region (2017-2022)
Table Europe Human Vaccines Sales () Forecast by Countries (2017-2022)
Figure Europe Human Vaccines Sales Market Share Forecast by Countries (2017-2022)
Table Europe Human Vaccines Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Europe Human Vaccines Revenue Market Share Forecast by Countries (2017-2022)
Table Middle East Human Vaccines Sales () Forecast by Countries (2017-2022)
Figure Middle East Human Vaccines Sales Market Share Forecast by Countries (2017-2022)
Table Middle East Human Vaccines Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Middle East Human Vaccines Revenue Market Share Forecast by Countries (2017-2022)
Table Africa Human Vaccines Sales () Forecast by Countries (2017-2022)
Figure Africa Human Vaccines Sales Market Share Forecast by Countries (2017-2022)
Table Africa Human Vaccines Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Africa Human Vaccines Revenue Market Share Forecast by Countries (2017-2022)
Table EMEA Human Vaccines Sales () Forecast by Type (2017-2022)
Figure EMEA Human Vaccines Sales Market Share Forecast by Type (2017-2022)
Table EMEA Human Vaccines Sales () Forecast by Application (2017-2022)
Figure EMEA Human Vaccines Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources